Filter News
Area of Research
News Topics
- (-) Biomedical (2)
- (-) Composites (2)
- (-) Materials Science (3)
- (-) Security (2)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (1)
- Artificial Intelligence (1)
- Bioenergy (6)
- Clean Water (1)
- Computer Science (3)
- Cybersecurity (1)
- Environment (4)
- Isotopes (1)
- Machine Learning (1)
- Neutron Science (9)
- Nuclear Energy (2)
- Physics (2)
- Summit (1)
- Sustainable Energy (5)
- Transportation (2)
Media Contacts
ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
Brixon, Inc., has exclusively licensed a multiparameter sensor technology from the Department of Energy’s Oak Ridge National Laboratory. The integrated platform uses various sensors that measure physical and environmental parameters and respond to standard security applications.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
For more than 50 years, scientists have debated what turns particular oxide insulators, in which electrons barely move, into metals, in which electrons flow freely.